| Year |
Citation |
Score |
| 2023 |
Katleba KD, Ghosh PM, Mudryj M. Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development. Biomedicines. 11. PMID 37626712 DOI: 10.3390/biomedicines11082215 |
0.334 |
|
| 2023 |
Jathal MK, Siddiqui S, Vasilatis DM, Durbin Johnson BP, Drake C, Mooso BA, D'Abronzo LS, Batra N, Mudryj M, Ghosh PM. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. The Journal of Biological Chemistry. 104973. PMID 37380074 DOI: 10.1016/j.jbc.2023.104973 |
0.355 |
|
| 2023 |
Katleba KD, Tsamouri MM, Jathal M, Baek HB, Armenta RB, Tepper CG, Cortopassi G, Ghosh PM, Mudryj M. Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Scientific Reports. 13: 1762. PMID 36720985 DOI: 10.1038/s41598-023-28692-z |
0.335 |
|
| 2021 |
Katleba K, Lombard AP, Tsamouri MM, Baek HB, Nishida KS, Libertini SJ, Platero AJ, Ma AH, Pan CX, Ghosh PM, Mudryj M. Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis. Cancer Letters. PMID 33549708 DOI: 10.1016/j.canlet.2021.01.029 |
0.326 |
|
| 2020 |
Kiss Z, Mudryj M, Ghosh PM. Non-circadian aspects of BHLHE40 cellular function in cancer. Genes & Cancer. 11: 1-19. PMID 32577154 DOI: 10.18632/Genesandcancer.201 |
0.421 |
|
| 2020 |
Siddiqui S, Libertini SJ, Lucas CA, Lombard AP, Baek HB, Nakagawa RM, Nishida KS, Steele TM, Melgoza FU, Borowsky AD, Durbin-Johnson BP, Qi L, Ghosh PM, Mudryj M. The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells. Cancer Letters. PMID 32330514 DOI: 10.1016/J.Canlet.2020.03.030 |
0.475 |
|
| 2018 |
Baek HB, Lombard AP, Libertini SJ, Fernandez-Rubio A, Vinall R, Gandour-Edwards R, Nakagawa R, Vidallo K, Nishida K, Siddiqui S, Wettersten H, Landesman Y, Weiss RH, Ghosh PM, Mudryj M. XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 9: 34567-34581. PMID 30349650 DOI: 10.18632/Oncotarget.26179 |
0.409 |
|
| 2017 |
D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. PMID 28745319 DOI: 10.1038/Onc.2017.233 |
0.387 |
|
| 2015 |
Lombard AP, Mudryj M. The emerging role of the androgen receptor in bladder cancer. Endocrine-Related Cancer. 22: R265-77. PMID 26229034 DOI: 10.1530/Erc-15-0209 |
0.365 |
|
| 2015 |
Lombard AP, Lim RM, Nakagawa RM, Vidallo KD, Libertini SJ, Platero AJ, Mudryj M. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncology Reports. 34: 1526-32. PMID 26166215 DOI: 10.3892/Or.2015.4117 |
0.394 |
|
| 2015 |
Lombard AP, Mooso BA, Libertini SJ, Lim RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM, Mudryj M. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Molecular Carcinogenesis. PMID 25865490 DOI: 10.1002/Mc.22319 |
0.342 |
|
| 2015 |
Savoy RM, Chen L, Siddiqui S, Melgoza FU, Durbin-Johnson B, Drake C, Jathal MK, Bose S, Steele TM, Mooso BA, D'Abronzo LS, Fry WH, Carraway KL, Mudryj M, Ghosh PM. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocrine-Related Cancer. 22: 369-86. PMID 25759396 DOI: 10.1530/Erc-15-0021 |
0.448 |
|
| 2015 |
Mudryj M, Siddiqui S, Libertini SJ, Lombard AP, Mooso B, D'Abronzo L, Melgoza F, Borowsky A, Drake C, Qi L, Ghosh PM. Abstract 5051: Androgen receptor-mediated regulation of p14ARF transcription in prostate tumor cells Cancer Research. 75: 5051-5051. DOI: 10.1158/1538-7445.Am2015-5051 |
0.472 |
|
| 2014 |
Lombard A, Mooso B, Libertini S, Lim R, Costanzo N, Ghosh P, Mudryj M. Abstract 5239: MiR-148a promotes apoptosis in urothelial cell carcinoma of the bladder cells in part by targeting DNMT1 Cancer Research. 74: 5239-5239. DOI: 10.1158/1538-7445.Am2014-5239 |
0.311 |
|
| 2014 |
Mudryj M, Libertini SJ, Lombard AP, Saddiqui S, Ghosh PM. Abstract 2124: Analysis of FAM111A, a newly identified AR regulated gene, in prostate cancer Cancer Research. 74: 2124-2124. DOI: 10.1158/1538-7445.Am2014-2124 |
0.479 |
|
| 2013 |
Mudryj M, Tepper CG. On the origins of the androgen receptor low molecular weight species. Hormones & Cancer. 4: 259-69. PMID 23860689 DOI: 10.1007/S12672-013-0152-Z |
0.399 |
|
| 2013 |
Mudryj M, Libertini SJ, Lombard AP. Abstract 3574: Studies of castrate resistant 22Rv1 cells identifies AR regulated interrelated networks of transcription factors, co-regulators, chromatin, and nuclear scaffolding proteins. Cancer Research. 73: 3574-3574. DOI: 10.1158/1538-7445.Am2013-3574 |
0.477 |
|
| 2013 |
Lombard A, Libertini S, Mudryj M. Abstract 3093: AR responsive miR-148a targets p27 and regulates the cell cycle in LNCaP cells. Cancer Research. 73: 3093-3093. DOI: 10.1158/1538-7445.Am2013-3093 |
0.415 |
|
| 2013 |
Lombard AP, Libertini S, Costanzo N, Lim R, Mudryj M. Abstract B226: MiR-148a dependent apoptosis of bladder cancer cells is mediated by the epigenetic modifier DNMT1. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B226 |
0.312 |
|
| 2012 |
Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocrine-Related Cancer. 19: 759-77. PMID 22993077 DOI: 10.1530/Erc-12-0171 |
0.422 |
|
| 2012 |
Libertini SJ, Chen H, al-Bataina B, Koilvaram T, George M, Gao AC, Mudryj M. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells. The Prostate. 72: 649-60. PMID 21837779 DOI: 10.1002/Pros.21468 |
0.376 |
|
| 2012 |
Libertini SJ, Mudryj M, Lombard AP, Chen H, Rodriguez V, Perez-Stable C, al-Bataina B, Koilvaram T, George M, Gao AC. Abstract B47: Identification of novel E2F3 transcriptional targets expands the role of the RB/E2F axis beyond cell cycle control Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-B47 |
0.476 |
|
| 2011 |
Jathal MK, Chen L, Mudryj M, Ghosh PM. Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry. 11: 131-149. PMID 21603064 DOI: 10.2174/187152211795495643 |
0.396 |
|
| 2011 |
Mudryj M, Libertini SJ, Chen H, Al-Bataina B, Kung H, Ghosh PM. Abstract 4541: Binding and transcriptional activity of the androgen receptor isoforms in 22Rv1 prostate cancer cells Cancer Research. 71: 4541-4541. DOI: 10.1158/1538-7445.Am2011-4541 |
0.472 |
|
| 2010 |
Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung HJ, Ghosh PM, Mudryj M. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocrine-Related Cancer. 17: 857-73. PMID 20634343 DOI: 10.1677/Erc-10-0081 |
0.472 |
|
| 2010 |
Chen H, Libertini SJ, Wang Y, Kung HJ, Ghosh P, Mudryj M. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. The Journal of Biological Chemistry. 285: 2368-74. PMID 19946123 DOI: 10.1074/Jbc.M109.049379 |
0.442 |
|
| 2010 |
Bose S, Wang Y, Siddiqui S, Mooso B, Vinall R, Tepper C, White RWd, Mudryj M, Ghosh PM. Abstract 1702: Androgen receptor antagonist bicalutamide sensitizes androgen-independent prostate cancer cells to mTOR inhibitor rapamycin by regulating phosphorylation of translation initiation suppressor eIF4E-binding protein 1 (4E-BP1) Cancer Research. 70: 1702-1702. DOI: 10.1158/1538-7445.Am10-1702 |
0.477 |
|
| 2009 |
Devlin HL, Mudryj M. Progression of prostate cancer: multiple pathways to androgen independence. Cancer Letters. 274: 177-86. PMID 18657355 DOI: 10.1016/J.Canlet.2008.06.007 |
0.406 |
|
| 2008 |
Devlin HL, Mack PC, Burich RA, Gumerlock PH, Kung HJ, Mudryj M, deVere White RW. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells. Molecular Cancer Research : McR. 6: 808-18. PMID 18505925 DOI: 10.1158/1541-7786.MCR-07-2027 |
0.372 |
|
| 2007 |
Libertini SJ, Tepper CG, Rodriguez V, Asmuth DM, Kung HJ, Mudryj M. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Research. 67: 9001-5. PMID 17909000 DOI: 10.1158/0008-5472.Can-07-1072 |
0.458 |
|
| 2006 |
Libertini SJ, Tepper CG, Guadalupe M, Lu Y, Asmuth DM, Mudryj M. E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis. The Prostate. 66: 70-81. PMID 16114066 DOI: 10.1002/Pros.20314 |
0.428 |
|
| 2005 |
Libertini SJ, Robinson BS, Dhillon NK, Glick D, George M, Dandekar S, Gregg JP, Sawai E, Mudryj M. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Research. 65: 10700-8. PMID 16322214 DOI: 10.1158/0008-5472.Can-05-1666 |
0.364 |
|
| 2003 |
Nguyen H, Mudryj M, Guadalupe M, Dandekar S. Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology. 312: 245-53. PMID 12890637 DOI: 10.1016/S0042-6822(03)00209-5 |
0.369 |
|
| 2003 |
Dhillon NK, Mudryj M. Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes and Immunity. 4: 336-342. PMID 12847548 DOI: 10.1038/Sj.Gene.6363973 |
0.373 |
|
| 2002 |
Dhillon NK, Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene. 21: 4626-34. PMID 12096339 DOI: 10.1038/Sj.Onc.1205576 |
0.394 |
|
| 2002 |
Ndolo T, Dhillon NK, Nguyen H, Guadalupe M, Mudryj M, Dandekar S. Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle. Journal of Virology. 76: 3587-95. PMID 11907198 DOI: 10.1128/Jvi.76.8.3587-3595.2002 |
0.33 |
|
| 2001 |
De Borja PF, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription Embo Journal. 20: 5737-5747. PMID 11598016 DOI: 10.1093/Emboj/20.20.5737 |
0.353 |
|
| 2000 |
Tepper CG, Seldin MF, Mudryj M. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. Experimental Cell Research. 260: 9-19. PMID 11010806 DOI: 10.1006/Excr.2000.4990 |
0.348 |
|
| 1997 |
Afshari CA, Rhodes N, Paules RS, Mudryj M. Deregulation of specific E2F complexes by the v-mos oncogene Oncogene. 14: 3029-3038. PMID 9223666 DOI: 10.1038/Sj.Onc.1201157 |
0.398 |
|
| 1992 |
Wade M, Kowalik TF, Mudryj M, Huang ES, Azizkhan JC. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Molecular and Cellular Biology. 12: 4364-4374. PMID 1328853 DOI: 10.1128/Mcb.12.10.4364 |
0.357 |
|
| 1992 |
Devoto SH, Mudryj M, Pines J, Hunter T, Nevins JR. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell. 68: 167-76. PMID 1310073 DOI: 10.1016/0092-8674(92)90215-X |
0.341 |
|
| 1991 |
Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A Cell. 65: 1243-1253. PMID 1829647 DOI: 10.1016/0092-8674(91)90019-U |
0.334 |
|
| 1991 |
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein Cell. 65: 1053-1061. PMID 1828392 DOI: 10.1016/0092-8674(91)90557-F |
0.378 |
|
| 1990 |
Mudryj M, Hiebert SW, Nevins JR. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway Embo Journal. 9: 2179-2184. PMID 2141565 DOI: 10.1002/J.1460-2075.1990.Tb07387.X |
0.389 |
|
| 1988 |
Mudryj M, de Crombrugghe B. Deletion analysis of the mouse alpha 1(III) collagen promoter. Nucleic Acids Research. 16: 7513-26. PMID 3412893 DOI: 10.1093/Nar/16.15.7513 |
0.325 |
|
| 1986 |
Setoyama C, Frunzio R, Liau G, Mudryj M, de Crombrugghe B. Transcriptional activation encoded by the v-fos gene. Proceedings of the National Academy of Sciences of the United States of America. 83: 3213-7. PMID 3010284 DOI: 10.1073/Pnas.83.10.3213 |
0.327 |
|
| Show low-probability matches. |